via Dublin Live
Researchers from Trinity have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma. The researchers have uncovered a critical role for a protein (Caspase-11), which had previously never been implicated in the disease.
They report their findings today in leading journal Nature Communications.
Lead author Zbigniew Zaslona, working with a team led by Luke O’Neill, Professor of Biochemistry in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute, has been exploring the role that inflammation plays in asthma – a very common and often serious disease of childhood.
Ireland has one of the highest incidences of asthma in Europe, which in its most severe form remains difficult to treat and can be fatal.
Caspase-11 is a protein with an important role in defending against bacteria, but the team in Trinity has found that when it is over-active it can provoke a damaging inflammatory reaction. When this happens, it is likely to be a key driver of allergic inflammation in the lungs of asthmatics.
Dr Zaslona said:
“Caspase-11 can cause cells to die, which is a very inflammatory event as the cells then release their contents, which can irritate tissues in our body. We have found that Caspase-11 is a key driver of inflammation in the airways in asthma. This causes the signs and symptoms of asthma which most notably involves difficulty breathing.”
Although symptoms of mild asthma can be managed with current therapies, severe asthma remains very difficult to treat and asthma rates are constantly on the rise.
Dr Zaslona added:
“A variety of irritants such as airborne pollutants, certain types of pollen and house dust mites can induce cell death in the lungs. Our work suggests that Caspase-11 is sensing these noxious things and causing disease.”
Professor O’Neill said:
“Caspase-11 – or it’s human equivalent, which is Caspase-4 – has never been implicated in asthma before so we think it holds great promise as a possible target for new drugs to treat this common, debilitating disease.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- News & Notes: Calais Campbell's Asthma Made Him Mull Opt-Outon August 7, 2020 at 12:05 pm
Calais Campbell sees a career year in sacks within reach. Rookie James Proche is expected to return punts. Matt Skura is still on schedule.
- Aerobic Training May Improve Asthma Control and Reduce Frequency of Rescue Medication Useon August 6, 2020 at 7:12 am
While both aerobic training and breathing exercises presented similar results for some aspects of asthma control, those undergoing ae ...
- Combination asthma medication is over-prescribed to Australian children—but dispensing patterns are improvingon August 6, 2020 at 6:31 am
Australian children—preschoolers in particular—are being inappropriately prescribed fixed dose combination (FDC) asthma medication, a UNSW Sydney big data study on asthma dispensing patterns has shown ...
- Asthma and Allergy Foundation of America (AAFA) Appoints Melanie Carver Chief Mission Officeron August 6, 2020 at 6:10 am
Carver to Lead Programmatic and Strategic Initiatives for AAFA Melanie Carver, AAFA's New Chief Mission OfficerWashington, D.C., Aug. 06, 2020 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of ...
- Asthma Medicine Not Proven as COVID-19 ‘Cure’on August 5, 2020 at 5:29 am
But the supposed “cure” is an asthma medication, touted by a Texas doctor, that has not yet been proven in clinical trials as an effective treatment for COVID-19 — though researchers are exploring its ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Targeting CD39 in canceron July 28, 2020 at 5:01 pm
The ATP–adenosine pathway functions as a key modulator of innate and adaptive immunity within the tumour microenvironment. Consequently, multiple clinical strategies are being explored to target ...
- Moving away from death: when caspase-11 meets cofilinon April 10, 2019 at 5:21 am
A novel pathway modulating inflammatory-cell migration in vivo that involves the unlikeliest of partners, the inflammatory caspase-11 and Aip1 (an activator of cofilin-mediated actin ...
- Dual Inhibition of Interleukin-1β and Interleukin-18: A New Treatment Option for Sepsis?on May 17, 2018 at 3:33 pm
Interestingly, they also studied caspase 1 deletion and caspase 1 plus caspase 11 (amplifier of caspase 1 activity) deficiency in their mouse studies. Caspase 1 is a cysteine-dependent ...